Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.32 USD | -2.01% | +4.29% | -2.47% |
Sep. 06 | Analyst recommendations: Broadcom, Qualcomm, Lululemon Athletica, Vertex Pharmaceuticals... | |
Aug. 16 | UBS Adjusts Price Target on VF to $17 From $12, Maintains Neutral Rating | MT |
Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 10.49B | 9.24B | 11.84B | 11.61B | 10.45B | |||||
Total Revenues | 10.49B | 9.24B | 11.84B | 11.61B | 10.45B | |||||
Cost of Goods Sold, Total | 4.67B | 4.33B | 5.38B | 5.51B | 5.01B | |||||
Gross Profit | 5.82B | 4.91B | 6.46B | 6.1B | 5.44B | |||||
Selling General & Admin Expenses, Total | 4.53B | 4.2B | 4.78B | 5.05B | 4.82B | |||||
Other Operating Expenses, Total | 4.53B | 4.2B | 4.78B | 5.05B | 4.82B | |||||
Operating Income | 1.29B | 711M | 1.68B | 1.05B | 624M | |||||
Interest Expense, Total | -92.04M | -136M | -136M | -174M | -245M | |||||
Interest And Investment Income | 19.87M | 9.16M | 5.01M | 9.76M | 21.63M | |||||
Net Interest Expenses | -72.18M | -126M | -131M | -165M | -223M | |||||
Currency Exchange Gains (Loss) | 10.3M | -137K | -219K | -10.36M | -253K | |||||
Other Non Operating Income (Expenses) | -69.84M | -3.62M | 4.81M | -18.16M | -1.9M | |||||
EBT, Excl. Unusual Items | 1.16B | 580M | 1.55B | 857M | 398M | |||||
Restructuring Charges | -31.8M | -119M | -20M | -75.7M | -111M | |||||
Merger & Related Restructuring Charges | - | -8.7M | - | - | - | |||||
Impairment of Goodwill | -323M | - | - | -394M | -508M | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | -42.36M | - | - | - | |||||
Asset Writedown | -14.6M | -35.16M | -6.4M | -344M | -39.4M | |||||
Legal Settlements | - | - | - | - | 29.1M | |||||
Other Unusual Items | -59.77M | 81.4M | -3.64M | - | -3.5M | |||||
EBT, Incl. Unusual Items | 727M | 456M | 1.52B | 43.29M | -234M | |||||
Income Tax Expense | 98.06M | 102M | 307M | -75.3M | 735M | |||||
Earnings From Continuing Operations | 629M | 355M | 1.22B | 119M | -969M | |||||
Earnings Of Discontinued Operations | 50.3M | 52.96M | 171M | - | - | |||||
Net Income to Company | 679M | 408M | 1.39B | 119M | -969M | |||||
Net Income - (IS) | 679M | 408M | 1.39B | 119M | -969M | |||||
Net Income to Common Incl Extra Items | 679M | 408M | 1.39B | 119M | -969M | |||||
Net Income to Common Excl. Extra Items | 629M | 355M | 1.22B | 119M | -969M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 1.72 | 1.05 | 3.55 | 0.31 | -2.49 | |||||
Basic EPS - Continuing Operations | 1.59 | 0.91 | 3.12 | 0.31 | -2.49 | |||||
Basic Weighted Average Shares Outstanding | 395M | 390M | 390M | 388M | 388M | |||||
Net EPS - Diluted | 1.7 | 1.05 | 3.53 | 0.31 | -2.49 | |||||
Diluted EPS - Continuing Operations | 1.57 | 0.91 | 3.1 | 0.31 | -2.49 | |||||
Diluted Weighted Average Shares Outstanding | 400M | 392M | 392M | 388M | 388M | |||||
Normalized Basic EPS | 1.83 | 0.93 | 2.49 | 1.38 | 0.64 | |||||
Normalized Diluted EPS | 1.81 | 0.92 | 2.47 | 1.38 | 0.64 | |||||
Dividend Per Share | 1.9 | 1.94 | 1.98 | 1.81 | 0.78 | |||||
Payout Ratio | 110.19 | 185.55 | 55.75 | 592.7 | -31.29 | |||||
American Depositary Receipts Ratio (ADR) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.56B | 968M | 1.94B | 1.3B | 943M | |||||
EBITA | 1.31B | 728M | 1.7B | 1.06B | 638M | |||||
EBIT | 1.29B | 711M | 1.68B | 1.05B | 624M | |||||
EBITDAR | 2.09B | 1.49B | 2.49B | 1.86B | 1.53B | |||||
Total Revenues (As Reported) | - | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 13.48 | 22.25 | 20.15 | -173.95 | -314.61 | |||||
Current Domestic Taxes | 15.51M | 31.84M | 268M | -128M | 371M | |||||
Current Foreign Taxes | 157M | 110M | 197M | 106M | 760M | |||||
Total Current Taxes | 173M | 141M | 464M | -21.74M | 1.13B | |||||
Deferred Domestic Taxes | 38.51M | -24.13M | -177M | -46.68M | -316M | |||||
Deferred Foreign Taxes | -113M | -15.68M | 19.89M | -6.88M | -78.63M | |||||
Total Deferred Taxes | -74.5M | -39.81M | -157M | -53.55M | -395M | |||||
Normalized Net Income | 723M | 363M | 971M | 536M | 249M | |||||
Interest on Long-Term Debt | 1.02M | 462K | 513K | 486K | 457K | |||||
Non-Cash Pension Expense | 9.11M | -21.46M | -21.56M | 91.25M | 3.16M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 756M | 608M | 841M | 862M | 836M | |||||
Selling and Marketing Expenses | 756M | 608M | 841M | 862M | 836M | |||||
Net Rental Expense, Total | 534M | 517M | 551M | 558M | 584M | |||||
Imputed Operating Lease Interest Expense | 98.37M | 89.31M | 85.01M | 104M | 147M | |||||
Imputed Operating Lease Depreciation | 435M | 428M | 466M | 454M | 437M | |||||
Stock-Based Comp., Other (Total) | 68.2M | 70.82M | 91.36M | 60.35M | 67.33M | |||||
Total Stock-Based Compensation | 68.2M | 70.82M | 91.36M | 60.35M | 67.33M |